Success Story: EB-1A Approved Without RFE! Our Firm Helped a Senior Research Specialist from China Secure Approval

Case Summary:     

The client—a biomedical science researcher with an M.D. and a Ph.D. in medicine—partnered with North America Immigration Law Group (Chen Immigration) to ensure a successful petition outcome from USCIS.

The client is internationally recognized for expertise in neurodevelopment, pediatric neurotoxicity, and anesthesiology. This work is particularly well-known for advancing understanding of how certain anesthetics, such as isoflurane, can affect neurological development — an area of urgent national interest as the U.S. medical community continues to refine safe pediatric clinical practices.

Our team carefully curated and presented compelling documentary evidence to demonstrate the extraordinary nature of the client’s contributions:

• 18 peer-reviewed journal articles, including 6 first-authored, showcase a strong record of research leadership and innovation.
• 280 citations, illustrating widespread reliance on the client’s findings by fellow biomedical scientists and clinical researchers worldwide.
• At least 19 professional peer-review assignments, confirming that respected journals rely on the client’s expertise to evaluate high-impact research in pediatric neurotoxicity and anesthesiology.
• Funding support connected to the National Institutes of Health (NIH), one of the most prestigious scientific agencies in the United States, further demonstrates the recognized importance of the client’s work.

To bolster the record further, we included four authoritative recommendation letters, each confirming the client’s distinguished reputation and the substantial benefit of continued research in the United States.

Our legal team presented a strong argument establishing that the client’s work directly addresses nationwide healthcare needs, including safer clinical procedures for vulnerable patient populations. The evidence clearly demonstrated that the client is among the small percentage of researchers at the top of the biomedical science field.

We are pleased to share that USCIS approved the client’s EB-1A I-140 petition, acknowledging both the exceptional merit of the case and the critical importance of the client’s research contributions. We are proud to support this talented researcher and look forward to seeing ongoing advancements in pediatric neuroprotection facilitated through continued work in the United States.